GSK has announced a licensing agreement with Hyderabad, India-based Bharat Biotech for its Shigella vaccine candidate, altSonflex 1-2-3. This collaboration signifies a step in addressing the global burden of Shigella, a bacterial infection that causes severe diarrhea and is responsible for thousands of deaths annually, predominantly among children under five....